<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moon J</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>7504</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10657364</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Nucleic acid detection powered by CRISPR technology provides a rapid, sensitive, and deployable approach to molecular diagnostics. While exciting, there remain challenges limiting its practical applications, such as the need for pre-amplification and the lack of quantitative ability. Here, we develop an asymmetric CRISPR assay for cascade signal amplification detection of nucleic acids by leveraging the asymmetric trans-cleavage behavior of competitive crRNA. We discover that the competitive reaction between a full-sized crRNA and split crRNA for CRISPR-Cas12a can induce cascade signal amplification, significantly improving the target detection signal. In addition, we find that CRISPR-Cas12a can recognize fragmented RNA/DNA targets, enabling direct RNA detection by Cas12a. Based on these f</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA.</pubmed_title><pmcid>PMC10657364</pmcid><funding_grant_id>U01CA269147</funding_grant_id><funding_grant_id>U01 CA269147</funding_grant_id><funding_grant_id>U01AI148306</funding_grant_id><funding_grant_id>U01 AI148306</funding_grant_id><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Moon J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA.</name><description>Nucleic acid detection powered by CRISPR technology provides a rapid, sensitive, and deployable approach to molecular diagnostics. While exciting, there remain challenges limiting its practical applications, such as the need for pre-amplification and the lack of quantitative ability. Here, we develop an asymmetric CRISPR assay for cascade signal amplification detection of nucleic acids by leveraging the asymmetric trans-cleavage behavior of competitive crRNA. We discover that the competitive reaction between a full-sized crRNA and split crRNA for CRISPR-Cas12a can induce cascade signal amplification, significantly improving the target detection signal. In addition, we find that CRISPR-Cas12a can recognize fragmented RNA/DNA targets, enabling direct RNA detection by Cas12a. Based on these f</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-19T06:36:05.302Z</modification><creation>2025-04-19T06:36:05.302Z</creation></dates><accession>S-EPMC10657364</accession><cross_references><pubmed>37980404</pubmed><doi>10.1038/s41467-023-43389-7</doi></cross_references></HashMap>